期刊文献+

胚肝细胞移植治疗Wilson病的初步研究 被引量:4

Amelioration of disturbed copper metabolism in TX mouse:a Wilson disease model, by fetal hepatocytes transplantation
原文传递
导出
摘要 目的 探讨胚肝细胞脾内移植对TX小鼠铜代谢紊乱的改善情况。方法 组织块酶消化法分离培养DL小鼠胚肝细胞 ,以Hoechst3332 4进行荧光标记后作为供体对TX小鼠进行脾内移植 ,检测移植后TX小鼠的血清铜蓝蛋白和血清铜水平 ,并进行病理学检查。结果 移植后 2周内 ,TX小鼠的铜蓝蛋白由 9 0U/L逐渐上升至 14 5U/L、血清铜由 0 3mg/L上升至 0 6mg/L(P <0 0 5 ) ,受体肝组织内可见供体细胞定居并呈结节样增生。结论 胚肝细胞脾内移植后可在受体肝组织中定居增生 ,并有效改善TX小鼠的铜代谢障碍 ,为Wilson病的治疗提供了新的思路。 Objective To investigate the possibility of amelionation of the disturbed metabolism by fetal hepatocytes transplantation in toxic milk mouse, a model of Wilson disease (WD). Methods The donor hepatocytes were harvested from the fetal livers of a normal pregnant DL mouse (D=13 days). The cells were labeled with fluorochrome Hoechst 33 342 and then transplanted into the spleens of TX mice. The serum copper and ceruloplasmin concentrations of the mice were determined after transplantation and histological investigation performed. Results Within 2 weeks after transplantation, the serum ceruloplasmin and copper concentrations increased gradually, (9.0±1.6) U/L vs. (14.5±3.8) U/L; (0.3±0.1) mg/L vs. (0.6±0.2) mg/L respectively, P <0.05, which ultimately rose from about 30% of the normal level to nearly 60%. Pathological examination showed that the donor cells could be visualized in mass of 5 to 8 cells in the liver of the recipients when sacrificed after transplantation. Conclusions The hereditary abnormalities of copper metabolism in TX mice could be corrected partially by intrasplentic transplantation of normal fetal hepatocytes. This approach suggested a new way for perspective clinical therapy of WD.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2004年第1期48-51,共4页 Chinese Journal of Neurology
基金 中山医科大学"2 11"工程重点建设项目 广东省自然科学基金资助项目 (0 10 70 5 )
关键词 胚肝细胞移植 WILSON病 细胞移植 肝豆状核变性 血浆铜蓝蛋白 Hepatolenticular degeneration Hepatocytes Cell transplantation Ceruloplasmin
  • 相关文献

参考文献10

  • 1VanderwerfSM,CooperMJ,StetsenkoIV ,etal.CopperspecificallyregulatesintercellularphosphorylationoftheWilson’sdiseaseprotein,ahumancopper transportingATPase[].Journal of Biochemistry.2001
  • 2KobayashiS,OchiaiT,HoriS ,etal.CoppermetabolismafterlivingdonorlivertransplantationforhepaticfailureofWilson’’sdiseasefromagenemutateddonor[].Hepato Gastroenterology.2001
  • 3PetersonBE.Hepatic"stem"cells:comingfullcircle[].BloodCellsMolDis.2001
  • 4Vassilopoulos G,Wang PR.Russell DW: Transplanted bone marrow regenerates liver by cell fusion[].Nature.2003
  • 5Grosby HA,Strain AJ.Adult liver stem cells: bone marrow,blood, or liver derived[].Gut.2001
  • 6Wang X,Willenbring H,Akkari Y,et al.Cell fusion is the principal source of bone-marrow-derived hepatocytes[].Nature.2003
  • 7Schaefer M,Hopkins RG,Failla ML,et al.Hepatocyte-specific localization and copper-dependent trafficking of the Wilson disease in the liver[].American Journal of Physiology.1999
  • 8Mercer JF.The molecular basis of copper-transport diseases[].Trends in Molecular Medicine.2001
  • 9Stracciari A,Tempestini A,Borghi A,et al.Effect of liver transplantation on neurological manifestations in Wilson disease[].Archives of Neurology.2000
  • 10Maurizio M,Gerunda G,Daniele N,et al.Hepatocyte transplantation as a treatment for glycogen storage disease type 1a[].The Lancet.2002

同被引文献45

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部